Barbara Tilley to Minocycline
This is a "connection" page, showing publications Barbara Tilley has written about Minocycline.
Connection Strength
0.291
-
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995 Jan 15; 122(2):81-9.
Score: 0.113
-
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol. 1997 Jul; 24(7):1295-302.
Score: 0.034
-
Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 1997 Mar; 40(3):419-25.
Score: 0.033
-
Another look at minocycline. Bull Rheum Dis. 1996 Dec; 45(8):6-7.
Score: 0.032
-
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 1996 Nov; 39(11):1802-7.
Score: 0.032
-
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
Score: 0.019
-
Caffeine and progression of Parkinson disease. Clin Neuropharmacol. 2008 Jul-Aug; 31(4):189-96.
Score: 0.018
-
Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA. J Rheumatol. 1999 May; 26(5):1065-7.
Score: 0.010